Solu Therapeutics

We're pioneering a powerful new platform to unlock antibody-intractable cell surface targets. Our proprietary CyTAC™ and TicTAC™ molecules combine the strengths of small molecules and antibodies, allowing us to target high-value drug discovery opportunities and rapidly advance high quality clinical candidates. Read more about our therapeutic platform on our new website! Visit https://lnkd.in/enhCTkPA #CyTACPlatform #TicTACPlatform #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

Next week, our Co-Founder and Chief Technology Officer Brandon Turunen, PhD, will join fellow #biopharma leaders for a fireside chat on “Patient-Centric Development” at the Longwood Healthcare Leaders Boston CEO event. The event will gather industry-leading thought leaders, executives, investors and academics to discuss a number of issues facing the biopharma industry from sourcing and discovery to mergers and acquisitions. Brandon’s panel will take place on Tuesday, October 29th at 11:20am ET at the Mandarin Oriental Hotel in Boston. Learn more and register for the event here: https://bit.ly/3XMlBit #LongwoodHealthcareLeaders #FutureOfMedicine #Biotechnology #TargetedTherapies

We were honored to once again support The Leukemia & Lymphoma Society’s Light the Night celebration at Boston Common. For the second year in a row, our team came together to shine a light on the fight against blood cancers, raising funds and awareness for critical research. Events like these not only connect us with the patient communities we serve, but also remind us why we’re so passionate about the work we do. Thank you to everyone who participated in this meaningful event. There’s still time to get involved – find out how you can support #LightTheNight here: https://bit.ly/47DUASG #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

Next month, our Chief Business Officer Michael Boretti, PhD, will attend BIO-Europe in Stockholm, taking place November 4-6. We’re looking forward to interacting with #LifeSciences and #DrugDiscovery leaders from around the globe to share more about our proprietary platform and approach targeting areas of unmet need. Register, schedule a 1x1 meeting, and learn more about the event here: https://bit.ly/3TFnXyi #BioEurope

Yesterday, Solu General Counsel Kelly Honohan joined the Eli Lilly and Company team at the Boston Business Journal Women Who Lead in Life Sciences event. The event featured two panels packed with some of the industry’s brightest minds and emerging voices. It was an inspiring day of discussions on leadership, innovation, and the future of life sciences, reflecting the broader impact of leaders like Kelly and the Solu team in driving progress across the industry. #bbjwwl #TeamSolu #WomenInScience #LifeScience

Join us next week on Thursday, October 17 at the The Leukemia & Lymphoma Society’s #LightTheNight celebration in Boston. We’re grateful for the opportunity to sponsor this event for the second year in a row and gather with our local community to raise funds for research and advocacy efforts that will support those impacted by blood cancers. Learn more and register for this year’s event here: https://bit.ly/47DUASG

We’re excited to announce that today our team officially moved into our new office and lab space at Lilly Gateway Labs in the Eli Lilly and Company Seaport Innovation Center in Boston! This marks an important milestone for Solu as we join Lilly and other cutting-edge #drugdevelopment companies in a space designed to inspire innovation. With state-of-the-art labs and a collaborative environment, we’re looking forward to advancing our work alongside some of the industry’s brightest minds. Together, we’re pushing the boundaries of #biotech to deliver the next generation of targeted therapies. #TeamSolu #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

Every member of our team works hard to advance our therapeutic platforms so that every patient can receive the care they deserve. Our commitment to innovation and patient-centered solutions drives us forward in our mission to make a meaningful difference in the world of medicine. Join us in our journey to transform patient care and make a lasting impact. Discover Solu’s story, learn about our mission, and meet our leadership team on our newly redesigned website: https://lnkd.in/eZUKdtYZ #TeamSolu #CyTACPlatform #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

#ICYMI: Last month, we announced our relocation to the new Eli Lilly and Company Seaport Innovation Center in Boston. This facility will serve as a central hub for our research and development activities. The state-of-the-art center features extensive lab space and will enable us to enhance our research capabilities and collaborate closely with other scientists and innovative #biotech companies. We look forward to leveraging this advanced environment to continue our work on therapies for complex diseases. Read more in The Boston Globe: https://bit.ly/3Boa80M Boston Globe Media #CyTACPlatform #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine

On #WorldCancerResearchDay, we join the global community in recognizing the critical efforts to fight cancer and honoring the collective contributions of patients, families, doctors, and researchers. We are proud to continue advancing our research dedicated to addressing unmet needs in the treatment of complex diseases including #prostatecancer and #CMML. To learn more about our #oncology programs and ongoing research, visit: https://lnkd.in/efAFUfRh #CyTACPlatform #DrugDevelopment #Biotechnology #TargetedTherapies #Biopharma #TherapeuticDevelopment #CellTherapy #MedicalBreakthroughs #FutureOfMedicine #PrecisionMedicine #Oncology